Monthly Archives: March 2019

CUGH 2019: Researchers say training, resources for the “private sector,” including traditional healers, will be critical to TB control

By on .

CHICAGO – To find the missing tuberculosis cases that go unreported each year, national TB programs will have to reach out to the places where the most people seek care, researchers said here. And that’s not in public hospitals or clinics where capacities to respond to TB already exist, but in the private sector in […]

STREAM Trial: Nine-month regimen for drug-resistant tuberculosis brings “promising cure rates”

By on .

A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the World Health Organization in 2011 guidelines, substantiates earlier observed findings showing comparable success rates between the two. The STREAM trial (Standard Treatment Regimen of Anti-Tuberculosis drugs for patients with […]

What we’re reading: Thoughts on the White House budget proposal against a plan to eliminate U.S. HIV incidence

By on .

Since the president’s Feb. 5 State of the Union address pledge to end transmissions of HIV in the United States in the next 10 years, and the release of a strategy the next day outlining plans to target the hardest hit counties and states, the most critical immediate unanswered questions have concerned funding for the […]

CROI 2019: PopART HIV prevention study brings confirmation but also questions

By on .

Door-to-door HIV counseling and testing, followed by immediate access to treatment led to incidence drops — but with a caveat . . . SEATTLE – When the PopART study began in Zambia and  South Africa five years ago, the measures it would test among roughly a million people were so obviously beneficial, that the results […]

CROI 2019: Will the “Düsseldorf patient” make three — further propelling cure research?

By on .

Five years after a stem cell transplant with the same critical factor as those received by the Berlin patient and the London patient, and four months after stopping antiretroviral treatment, a Düsseldorf man remains virally suppressed SEATTLE – Exemplifying both the caution and the optimism essential to HIV cure science, Dr. Björn-Erik Ole Jensen won’t […]

CROI 2019: Two “game changing regimens” together show promise for preventing TB in people living with HIV

By on .

SEATTLE – A new and shorter drug regimen to prevent tuberculosis illness can safely be given to people with HIV who are on antiretroviral treatment regimens that include dolutegravir, researchers here announced. The finding is good news for people living with HIV for two reasons. The new regimen – consisting of the TB drugs isoniazid […]

CROI 2019: Point-of-care viral load testing improves HIV outcomes, researchers say

By on .

SEATTLE – People living with HIV who undergo HIV viral load testing at the point of health care delivery and receive their results immediately go on to achieve undetectable viral loads at higher rates than people whose  testing is done at laboratories, researchers said here. Results from the Simplifying HIV Treatment and Monitoring – or […]

CROI 2019: The case of the London patient adds validation to one approach towards a cure

By on .

SEATTLE – If you’re counting those in lasting remission from HIV, Dr. John Mellors of the University of Pittsburgh said here today, there’s been a doubling in their numbers. Now there are two. The dry tone of Mellor’s remarks, and the circumspect wording of Dr. Ravindra Gupta, the physician researcher of University College London, who he […]

CROI 2019: Thailand’s strides spanned HIV treatment, prevention and research

By on .

SEATTLE – The first HIV vaccine trials to yield signs of hope happened here. Thailand was also the first Asian country to eliminate mother-to-child transmission of HIV. Now, Thailand has achieved the first part of UNAIDS’ 90-90-90 targets: 98 percent of people infected with HIV know their status. Of that, 70 percent are receiving HIV […]